Dose adjustments in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)

被引：1

作者：

Highland, Kristin B. ^{[1
]}

Kuwana, Masataka ^{[2
]}

Azuma, Arata ^{[3
]}

Fischer, Aryeh ^{[4
]}

Maher, Toby M. ^{[5
,6
]}

Mayes, Maureen D. ^{[7
]}

Raghu, Ganesh ^{[8
]}

Girard, Mannaig ^{[9
]}

Kohlbrenner, Veronika ^{[10
]}

Clerisme-Beaty, Emmanuelle ^{[11
]}

Alves, Margarida ^{[11
]}

Distler, Oliver ^{[12
]}

机构：

[1] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA

[2] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan

[3] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan

[4] Univ Colorado, Sch Med, Denver, CO USA

[5] Imperial Coll London, Natl Heart & Lung Inst, London, England

[6] Royal Brompton Hosp, Res Clin Res Facil, Natl Inst Hlth, London, England

[7] Univ Texas Houston, McGovern Med Sch, Div Rheumatol & Clin Immunogenet, Houston, TX USA

[8] Univ Washington, Seattle, WA 98195 USA

[9] Boehringer Ingelheim France SAS, Reims, France

[10] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA

[11] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[12] Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland

来源：

EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷

关键词：

D O I：

10.1183/13993003.congress-2019.PA4731

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA4731

引用

页数：2

共 50 条

[1] Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
Kreuter, M.
Highland, K. B.
Kuwana, M.
Azuma, A.
Maher, T.
Mayes, M. D.
Raghu, G.
Girard, M.
Kohlbrenner, V
Clerisme-Beaty, E.
Alves, M.
Distler, O.
PNEUMOLOGIE, 2020, 74 : S55 - S56
[2] Changes in FVC in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
Highland, Kristin B.
Azuma, Arata
Fischer, Aryeh
Kuwana, Masataka
Maher, Toby M.
Mayes, Maureen D.
Raghu, Ganesh
Girard, Mannaig
Alves, Margarida
Gahlemann, Martina
Distler, Oliver
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[3] Changes in FVC in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)
Kreuter, M.
Highland, K. B.
Azuma, A.
Kuwana, M.
Maher, T. M.
Mayes, M. D.
Raghu, G.
Girard, M.
Alves, M.
Gahlemann, M.
Distler, O.
PNEUMOLOGIE, 2020, 74 : S56 - S57
[4] Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS trial
Maher, Toby
Distler, Oliver
Azuma, Arata
Fischer, Aryeh
Highland, Kristin B.
Kuwana, Masataka
Mayes, Maureen D.
Wachtlin, Daniel
Alves, Margarida
Gahlemann, Martina
Stowasser, Susanne
Raghu, Ganesh
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[5] Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS Trial
Prasse, A.
Maher, T. M.
Distler, O.
Azuma, A.
Highland, K. B.
Kuwana, M.
Mayes, M. D.
Wachtlin, D.
Alves, M.
Gahlemann, M.
Stowasser, S.
Raghu, G.
PNEUMOLOGIE, 2020, 74 : S57 - S57
[6] Effects of Nintedanib in Patients With Systemic Sclerosis-associated ILD (SSc-ILD) and Differing FVC at Baseline: The SENSCIS Trial
Maher, Toby
Distler, Oliver
Azuma, Arata
Highland, Kristin
Kuwana, M.
Mayes, Maureen
Watchlin, Daniel
Alves, Margardia
Gahlemann, Martina
Bell, Karen
Stowasser, Susanne
Raghu, Ganesh
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1085 - 1085
[7] Nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD): the SENSCIS trial
Prasse, A.
Distler, O.
Highland, K. B.
Gahlemann, M.
Azuma, A.
Mayes, M. D.
Raghu, G.
Sauter, W.
Girard, M.
Alves, M.
Clerisme-Beaty, E.
Kuwana, M.
Maher, T. M.
PNEUMOLOGIE, 2020, 74 : S57 - S58
[8] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): The SENSCIS Trial
Distler, O.
Highland, K. B.
Gahlemann, M.
Azuma, A.
Fischer, A.
Mayes, M.
Raghu, G.
Sauter, W.
Girard, M.
Alves, M.
Clerisme-Beaty, E.
Kuwana, M.
Maher, T. M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[9] Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing extents of lung fibrosis: the SENSCIS trial
Wiewrodt, R.
Raghu, G.
Distler, O.
Azuma, A.
Highland, K. B.
Kuwana, M.
Mayes, M. D.
Wachtlin, D.
Stowasser, S.
Alves, M.
Gahlemann, M.
Maher, T. M.
PNEUMOLOGIE, 2020, 74 : S58 - S59
[10] Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing extents of lung fibrosis: the SENSCIS trial
Raghu, Ganesh
Distler, Oliver
Azuma, Arata
Fischer, Aryeh
Highland, Kristin B.
Kuwana, Masataka
Mayes, Maureen D.
Wachtlin, Daniel
Stowasser, Susanne
Alves, Margarida
Gahlemann, Martina
Maher, Toby M.
EUROPEAN RESPIRATORY JOURNAL, 2019, 54

← 1 2 3 4 5 →